Lyell Wealth Management, Lp
Source: SEC Form 13F · as of Mar 2026Lyell Wealth Management, Lp holds 13 biotech & pharma companies tracked by BioSniper, totaling $27.7M in value as of Mar 2026 (SEC Form 13F).
Companies held
13
Total value held
$27.7M
| Company | Shares | Value |
|---|---|---|
| IDXXIDEXX LABORATORIES INC /DE | 22,517 | $12.7M |
| ABTABBOTT LABORATORIES | 64,501 | $6.6M |
| LLYELI LILLY & Co | 2,724 | $2.5M |
| JNJJOHNSON & JOHNSON | 8,343 | $2.0M |
| GILDGILEAD SCIENCES, INC. | 7,276 | $1.0M |
| MRKMerck & Co., Inc. | 5,675 | $683K |
| AMGNAMGEN INC | 1,664 | $585K |
| ABBVAbbVie Inc. | 1,968 | $428K |
| BMYBRISTOL MYERS SQUIBB CO | 5,595 | $339K |
| PRCTPROCEPT BioRobotics Corporation | 11,440 | $286K |
| AZNASTRAZENECA PLC | 1,377 | $272K |
| NVSNovartis AG | 1,405 | $215K |
| SANASana Biotechnology, Inc. | 10,500 | $30K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.